Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7

Journal of Medical Virology

Volumn 77, Issue 4, 2005, Pages 475-480

  Tan, Geok Hun ^a   Yusoff, Khatijah ^a   Seow, Heng Fong ^a   Tan, Wen Siang ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

HBsAg; HBV; Immunodominant region; Immunology; Phage display; T7 phage

Indexed keywords

CAPSID PROTEIN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT PROTEIN;

ANTIGENICITY; ARTICLE; BACTERIOPHAGE T7; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT; VIRUS HEPATITIS; WESTERN BLOTTING;

BACTERIOPHAGE T7; EPITOPES, B-LYMPHOCYTE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; PEPTIDE LIBRARY;

HEPATITIS B VIRUS; MIRIDAE; ORYCTOLAGUS CUNICULUS; T7 PHAGE;

EID: 27744479149     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20479     Document Type: Article

References (26)

1. Ashton-Rickardt PG, Murray K. 1989. Mutations that change the immunological subtype of hepatitis B virus surface antigen and distinguish between antigenic and immunogenic determinant. J Med Virol 29:204-214.
2. Benhar I.2001. Biotechnological applications of phage and cell display. Biotech Advances 19:1-33.
3. Cooreman MP, Leroux-Roels G, Paulij WP. 2001. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8:237-247.
4. Dreesman GR, Hollinger RB, McCombs RM, Melnick JL. 1973. Alteration on HBsAg determinants by reduction and alkylation. J Gen Virol 19:129-134.
5. Gerin JL, Alexander H, Shih JW-K, Purcell RH, Dopolito G, Engle R, Green N, Sutcliffe JG, Shihnick TM, Lerner RA. 1983. Chemically synthesised peptides of HBsAg duplicate the d/y subtype specificities and induced subtype specific antibodies in chimpanzees. Proc Natl Acad Sci USA 80:2365-2369.
6. Houshmand H, Froman G, Magnusson G. 1999. Use of bacteriophage T7 displayed peptides for determination of monoclonal antibodies specificity and biosensor analysis of the binding reaction. Anal Biochem 268:363-370.
7. Jiang J, Abu-Shilbayeh L, Rao VB. 1997. Display of a PorA peptide from Neisseria meningitidis on the bacteriophage T4 capsid. Infect Immun 65:4770-4777.
8. Kim EJ, Yoo SK. 1999. Cell surface display of hepatitis B virus surface antigen by using Pseudomonas syringae ice nucleation protein. Lett Appl Microbiol 29:292-297.
9. Kok WL, Yusoff K, Nathan S, Tan WS. 2002. Cloning, expression and display of the PreS domain of hepatitis B virus on filamentous bacteriophage M13. J Biochem Mol Biol Biophy 6:55-58.
10. Lindqvist BH, Naderi S. 1995. Peptide presentation by bacteriophage P4. FEMS Microbio Rev 17:33-39.
11. Mastico RA, Talbot SJ, Stockley PG. 1993. Multiple presentation of foreign peptides on the surface of an RNA-free spherical bacteriophage capsid. J Gen Virol 74:541-548.
12. McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hiieman MR. 1984. Human hepatitis B vaccine from recombinant yeast. Nature 307:178-180.
13. Murray K, Bruce SA, Wingfield P, van Eerd P, De Reus A, Schellekens H. 1984. Hepatitis B virus antigen made in microbial cells immunise against viral infection. EMBO J. 3:645-650.
14. Murray K, Shiau AL. 1999. The core antigen of hepatitis B virus as a carrier for immunogenic peptides. Biol Chem 380:277-283.
15. Pumpens P, Grens E. 2001. HBV core particles as a carrier for B cell/T cell epitopes. Intervirol. 44:98-114.
16. Rosenberg A, Griffin K, Studier W, McCormick M, Berg J, Novy R, Mierendorf R. 1996. T7 Select phage display system: A powerful new protein display system based on bacteriophage T7. Novations Novagen Newslett 6:1-6.
17. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning. A laboratory manual, 2nd edition Cold Spring Harbor: Cold Spring Harbor Laboratories Press.
18. Santini C, Brennam D, Mennuni C, Hoess RH, Nicosia A, Cortese R, Luzzago A. 1998. Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda. J Mol Biol 282:125-135.
19. Shiau A-L, Murray K. 1997. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen. J Med Virol 51:159-166.
20. Stahl SJ, Murray K. 1989. Immunogenicity of peptide fusions to hepatitis virus core antigen. Proc Natl Acad Sci USA 86:6283-6287.
21. Sternberg N, Hoess RH. 1995. Display of peptides and proteins on the surface of bacteriophage lambda. Proc Natl Acad Sci USA 92:1609-1613.
22. Sukeno N, Shirachi R, Yamaguchi N, Ishida N. 1972. Reduction and reoxidation of Australia antigen: Loss and reconstitution of particle structure and antigenicity. J Virol 9:182-184.
23. Szmuness W, Stevens CE, Harley EJ, Zhang A, Olwszko WR, William DC, Sodovsky R, Morrison JM, Kellner A. 1980. Hepatitis B vaccine: Demonstration of efficiency in a controlled clinical trial in a high-risk population in the United States. N Eng J Med 303:833-841.
24. Tan WS, Dyson MR, Murray K. 1999. Two distinct segments of the hepatitis B virus surface antigen contribute synergistically to its association with the viral core particles. J Mol Biol 286:797-808.
25. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. 1982. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347-350.
26. Vyas GN, Rao DR, Ibrahim AB. 1972. Australia antigen (hepatitis B antigen). A conformation antigen dependent on disulphide bonds. Science 178:1300-1301.